CTI Biopharma’s cancer drug fails late-stage trial, shares tumble
(Reuters) – CTI Biopharma Corp said on Monday its treatment for a type of blood cancer did not meet the…
by October Gallery
(Reuters) – CTI Biopharma Corp said on Monday its treatment for a type of blood cancer did not meet the…